ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · IEX Real-Time Price · USD
5.31
-0.01 (-0.19%)
At close: Apr 25, 2024, 4:00 PM
5.30
-0.01 (-0.19%)
After-hours: Apr 25, 2024, 7:30 PM EDT
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $143.24 million as of April 25, 2024. Its market cap has decreased by -44.99% in one year.
Market Cap
143.24M
Enterprise Value
134.05M
1-Year Change
-44.99%
Ranking
Category
Stock Price
$5.31
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $143.24M, an increase of 372.75%. That is a compound annual growth rate of 13.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 143.50M | -3.30% |
Apr 23, 2024 | 148.40M | -0.13% |
Apr 22, 2024 | 148.60M | 3.34% |
Apr 19, 2024 | 143.80M | -1.10% |
Apr 18, 2024 | 145.40M | -2.55% |
Apr 17, 2024 | 149.20M | -0.86% |
Apr 16, 2024 | 150.50M | -0.53% |
Apr 15, 2024 | 151.30M | -3.45% |
Apr 12, 2024 | 156.70M | -6.34% |
Apr 11, 2024 | 167.30M | 0.66% |
Apr 10, 2024 | 166.20M | -3.43% |
Apr 9, 2024 | 172.10M | 1.59% |
Apr 8, 2024 | 169.40M | -2.36% |
Apr 5, 2024 | 173.50M | 0.81% |
Apr 4, 2024 | 172.10M | -3.31% |
Apr 3, 2024 | 178.00M | 2.30% |
Apr 2, 2024 | 174.00M | -4.19% |
Apr 1, 2024 | 181.60M | -0.98% |
Mar 28, 2024 | 183.40M | 1.16% |
Mar 27, 2024 | 181.30M | 2.78% |
Mar 26, 2024 | 176.40M | -2.97% |
Mar 25, 2024 | 181.80M | 2.60% |
Mar 22, 2024 | 177.20M | -3.70% |
Mar 21, 2024 | 184.00M | -2.54% |
Mar 20, 2024 | 188.80M | 0.27% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
I-Mab | 150.21M |
Butterfly Network | 148.95M |
Regulus Therapeutics | 145.33M |
Biodesix | 144.33M |
Electromed | 143.97M |
Scilex Holding Company | 141.26M |
Annovis Bio | 140.28M |
Repare Therapeutics | 139.20M |